shasqi

Targeting Cancer with Click Chemistry

HealthcareDrug Discovery and DeliveryBiotechTherapeutics

Company facts

Growth-stage
Founded
2015
Employees
28
Headquarters
United States
Type
Private

About

Shasqi is leading the development of therapeutics leveraging click chemistry to get active cancer treatments to tumors with its proprietary CAPAC™ platform. Our technology is based on localizing a click chemistry reagent in the tumor area, which then activates a second agent, a systemically infused protodrug. When the two 'click', a powerful localized therapy is activated at the tumor, while keeping its systemic exposure levels below toxic thresholds.